Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14751
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorWongsawatkul O.
dc.contributor.authorSuksrichavalit T.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:37:01Z-
dc.date.available2021-04-05T03:37:01Z-
dc.date.issued2010
dc.identifier.issn1450216X
dc.identifier.other2-s2.0-79953832742
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14751-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-79953832742&partnerID=40&md5=8686afc28f2c75da18b012a0bee6d525
dc.description.abstractEclipta prostrata Linn (Compositae), a traditional medicine has been used for treatment of diverse symptoms e.g. hyperlipidemia, atherosclerosis and skin diseases. This study, hexane extract of E. prostrata Linn was evaluated for bioactivities. The extract showed its new action as a potential vasorelaxant. Moreover, antioxidative (SOD and DPPH assays) and cytotoxic activities of the extract were also observed. Isolation of the extract provided a stigmasterol including eight fractions of triterpenoids along with long chain hydrocarbons. All the fractions exhibited antimicrobial activity with minimum inhibitory concentration (MIC) range of 64-256 μg/mL. The results imply therapeutic value of the plant species as an alternative medicinal source of potential vasorelaxants. © EuroJournals Publishing, Inc. 2010.
dc.titleBioactivity evaluation of eclipta prostrata linn: A potential vasorelaxant
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationEuropean Journal of Scientific Research. Vol 44, No.2 (2010), p.167-176
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.